# Verbreding van screening op primair aldosteronisme: consensus tussen richtlijnen

*geplaatst 2026-02-06 · Hypertensie · Hypertension · doi https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.125.26228 · https://hartvaat.nl/2026/02/06/verbreding-van-screening-op-primair-aldosteronisme-consensus-tussen-richtlijnen/*

Minder dan 2% van de patiënten die in aanmerking komen wordt gescreend op primair aldosteronisme, ondanks bewijs dat vroege detectie en gerichte therapie het cardiovasculaire en renale risico verlagen. Dit artikel vergelijkt recente richtlijnupdates over screening.

## English: Broadening Primary Aldosteronism Screening: Alignment Across Contemporary Guidelines

This Hypertension article advocated for broadening primary aldosteronism screening, noting that fewer than 2% of eligible patients are currently screened despite evidence that early detection and targeted therapy improve cardiovascular outcomes.

## Abstract (original, from the publication)

Hypertension, Volume 83, Issue 5, Page e26228, May 1, 2026. Fewer than 2% of eligible patients are screened for primary aldosteronism, despite evidence that early detection and targeted therapy are associated with lower cardiovascular and kidney morbidity. Recent updates to major hypertension and endocrine guidelines reflect growing recognition that primary aldosteronism is far more prevalent than previously understood and that broader, more practical screening approaches are needed. These recommendations increasingly extend screening beyond resistant hypertension to adults with stage 2 hypertension and even to all individuals with hypertension. They also aim to lower barriers to testing through more flexible guidance on antihypertensive medication management, reaffirm the aldosterone-to-renin ratio as the preferred initial test, and provide more standardized criteria for interpretation. Supporting evidence includes epidemiological data demonstrating a continuum of renin-independent al

Auteurs: Lily Owei

---
Bron: Hypertension, https://doi.org/https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.125.26228. Bijgewerkt 2026-07-03T13:24:50Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.